19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
Conditions: Diffuse Large B Cell Lymphoma; Primary Mediastinal Large B Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B Cell Lymphoma; Chronic Lymphocytic Leukemia; Indolent Non-Hodgkin Lymphoma; Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia; Bur kitt's Lymphoma; Primary CNS Lymphoma Intervention: Drug: 19(T2)28z1xx CAR T cells Sponsors: Memorial Sloan Kettering Cancer Center; Takeda Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Leukemia | Lymphoma | Macroglobulinemia | Research | Waldenstrom's Macroglobulinemia